Showing results (181-190 of 232) with videos related to
Sort By:
Pageof 24
Inflammatory Bowel Diseases|October 24, 2024
Three-Year Efficacy and Safety of Mirikizumab Following 152 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension StudyBruce E Sands, Geert D'Haens, David B Clemow, et al.Journal of Crohn'S & Colitis|May 23, 2018
Autologous Haematopoietic Stem Cell Transplantation for Crohn's Disease: A Retrospective Survey of Long-term Outcomes From the European Society for Blood and Marrow TransplantationCharlotte K Brierley, Cristina Castilla-Llorente, Myriam Labopin, et al.Scandinavian Journal of Gastroenterology|March 14, 2007
Treatment inferred disease severity in Crohn's disease: evidence for a European gradient of disease courseFrank L Wolters, Catelijne Joling, Maurice G Russel, et al.Nature Genetics|December 23, 2008
Common variants in the NLRP3 region contribute to Crohn's disease susceptibilityAlexandra-Chloé Villani, Mathieu Lemire, Geneviève Fortin, et al.Inflammatory Bowel Diseases|March 9, 2024
Two-Year Efficacy and Safety of Mirikizumab Following 104 Weeks of Continuous Treatment for Ulcerative Colitis: Results From the LUCENT-3 Open-Label Extension StudyBruce E Sands, Geert D'Haens, David B Clemow, et al.Gastroenterology|February 26, 2026
Uncovering the dynamics of mucosa-associated microbiota in post-operative recurrence of Crohn's diseaseLéonard Dubois, Alexandre Chaussard, Philippe Seksik, et al.Inflammatory Bowel Diseases|February 6, 2007
Role of ASCA and the NOD2/CARD15 mutation Gly908Arg in predicting increased surgical costs in Crohn's disease patients: a project of the European Collaborative Study Group on Inflammatory Bowel DiseaseShmuel Odes, Michael Friger, Hillel Vardi, et al.Journal of Crohn'S & Colitis|September 24, 2011
Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up studyKonstantinos H Katsanos, Athina Tatsioni, Natalia Pedersen, et al.Journal of Crohn'S & Colitis|December 19, 2023
Outcomes and Endpoints of Postoperative Recurrence in Crohn's Disease: Systematic Review and Consensus ConferenceNassim Hammoudi, David Sachar, Geert D'Haens, et al.Journal of Crohn'S & Colitis|May 5, 2025
Differential effects of tofacitinib on macrophage activation contribute to lack of response in ulcerative colitis patientsElisa Melón-Ardanaz, Marisol Veny, Ana M Corraliza, et al.Pageof 24